User menu

Sunitinib (SU) vs placebo for treatment of progressive, well-differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial

Bibliographic reference Raoul, J. L. ; Borbath, Ivan ; Niccoli, P. ; Bang, Y. J. ; Lombard-Bohas, C. ; et. al. Sunitinib (SU) vs placebo for treatment of progressive, well-differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial.15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology (Berlin (Germany), Sep 20-24, 2009). In: EJC - Supplements, Vol. 7, no. 2, p. 361-361 (2009)
Permanent URL http://hdl.handle.net/2078.1/58668